Eagle Pharmaceuticals Inc (EGRX) – Strategy, SWOT and Corporate Finance Report

Eagle Pharmaceuticals Inc (EGRX) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Eagle Pharmaceuticals Inc (Eagle) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s key commercial products encompass pharmaceutical injectables, including Ryanodex for exertional heatstroke; Bendeka, and Belrapzo, both for the treatment of chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin’s lymphoma (NHL). Pipeline products of the company include EP-4104 (dantrolene sodium) for exertional heat stroke (EHS) and nerve agent exposure; EA-114 (fulvestrant) for the treatment of breast cancer and Vasopressin injection for blood pressure. The company’s products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in Woodcliff Lake, New Jersey, the US.

Scope

• Detailed information on Eagle Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Eagle Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of Eagle Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about Eagle Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Eagle Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Eagle Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Eagle Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

CTI BioPharma Corp

Spectrum Pharmaceuticals Inc

Elite Laboratories Inc

Mylan Institutional LLC

Impax Laboratories Inc, 1490 Crocker Avenue, Hayward, California, United States

Endo International Plc

US WorldMeds LLC

Hikma Pharmaceuticals USA Inc

Endo International Plc

Ariad Pharmaceuticals Inc

Hikma Pharmaceuticals USA Inc

Eli Lilly and Co

Celgene Corp

Merck & Co Inc

Elite Laboratories Inc

Spectrum Pharmaceuticals Inc

Amgen Inc

Genentech USA Inc

AbbVie Inc

Regeneron Pharmaceuticals Inc

CTI BioPharma Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Eagle Pharmaceuticals Inc - Key Facts

Eagle Pharmaceuticals Inc - Key Employees

Eagle Pharmaceuticals Inc - Key Employee Biographies

Eagle Pharmaceuticals Inc - Major Products and Services

Eagle Pharmaceuticals Inc - History

Eagle Pharmaceuticals Inc - Company Statement

Eagle Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Eagle Pharmaceuticals Inc - Business Description

Product Category: License and Other Revenue

Performance

Product Category: Product Sales

Performance

Product Category: Royalty Revenue

Performance

R&D Overview

Eagle Pharmaceuticals Inc - Corporate Strategy

Eagle Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Eagle Pharmaceuticals Inc - Strengths

Eagle Pharmaceuticals Inc - Weaknesses

Eagle Pharmaceuticals Inc - Opportunities

Eagle Pharmaceuticals Inc - Threats

Eagle Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Eagle Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 09, 2023: Eagle Pharmaceuticals reports first quarter 2023 results

Mar 13, 2023: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results

Mar 03, 2023: Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023

Dec 01, 2022: Eagle Pharmaceuticals’ Investor Day to Focus on Acute Care Products and Pipeline Programs; Tuesday, December 6, 2022, at 8:00am ET at the Lotte New York Palace

Nov 16, 2022: Eagle Pharmaceuticals’ Investor Day to Feature World-Renowned KOLs on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel

Nov 09, 2022: Eagle Pharmaceuticals Reports Third Quarter 2022 Results

Oct 31, 2022: Eagle Pharmaceuticals to Host Third Quarter 2022 Financial Results on November 7, 2022

Oct 19, 2022: Eagle Pharmaceuticals to Host Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel

Aug 09, 2022: Eagle Pharmaceuticals Reports Second Quarter 2022 Results

Jul 18, 2022: Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Eagle Pharmaceuticals Inc, Key Facts

Eagle Pharmaceuticals Inc, Key Employees

Eagle Pharmaceuticals Inc, Key Employee Biographies

Eagle Pharmaceuticals Inc, Major Products and Services

Eagle Pharmaceuticals Inc, History

Eagle Pharmaceuticals Inc, Subsidiaries

Eagle Pharmaceuticals Inc, Key Competitors

Eagle Pharmaceuticals Inc, Ratios based on current share price

Eagle Pharmaceuticals Inc, Annual Ratios

Eagle Pharmaceuticals Inc, Annual Ratios (Cont…1)

Eagle Pharmaceuticals Inc, Annual Ratios (Cont…2)

Eagle Pharmaceuticals Inc, Interim Ratios

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Eagle Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Eagle Pharmaceuticals Inc, Performance Chart (2018 – 2022)

Eagle Pharmaceuticals Inc, Ratio Charts

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports